Evidence map›Paper›PMID 40034755›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Geographic and age-related variations in mutational processes in colorectal cancer.

Marcos Díaz-Gay, Wellington Dos Santos, Sarah Moody, Mariya Kazachkova, Ammal Abbasi, Christopher D Steele, Raviteja Vangara, Sergey Senkin, Jingwei Wang, Stephen Fitzgerald and 53 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

63 authors.

Marcos Díaz-GayDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Wellington Dos SantosGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Sarah MoodyCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Mariya KazachkovaDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Ammal AbbasiDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Christopher D SteeleDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Raviteja VangaraDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Sergey SenkinGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Jingwei WangCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Stephen FitzgeraldCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Erik N BergstromDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Azhar KhandekarDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Burçak OtluDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Behnoush Abedi-ArdekaniGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Ana Carolina de CarvalhoGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Thomas CattiauxGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Ricardo Cortez Cardoso PenhaGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Valérie GaborieauGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Priscilia ChopardGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Christine CarreiraEvidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Saamin CheemaCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Calli LatimerCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Jon W TeagueCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Anush MukeriyaClinical Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.
David ZaridzeClinical Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.
Riley CoxOntario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Monique AlbertOntario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Larry PhouthavongsyOntario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Steven GallingerLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Reza MalekzadehDigestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadreza NiavaraniDigestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Marko MiladinovClinic for Digestive Surgery - First Surgical Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
Katarina ErićDepartment of Pathology, University Clinical Centre of Serbia, Belgrade, Serbia.
Sasa MilosavljevicInternational Organization for Cancer Prevention and Research, Belgrade, Serbia.
Suleeporn SangrajrangNational Cancer Institute, Bangkok, Thailand.
Maria Paula CuradoDepartment of Epidemiology, A.C. Camargo Cancer Center, Sao Paulo, Brazil.
Samuel AguiarColon Cancer Reference Center, A.C. Camargo Cancer Center, Sao Paulo, Brazil.
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Monise Tadin ReisDepartment of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
Luis Gustavo RomagnoloDepartment of Colorectal Oncology Surgery, Barretos Cancer Hospital, Barretos, Brazil.
Denise Peixoto GuimarãesDepartment of Endoscopy, Barretos Cancer Hospital, Barretos, Brazil.
Ivana HolcatovaInstitute of Public Health & Preventive Medicine, 2 Faculty of Medicine, Charles University, Prague, Czech Republic.
Jaroslav KalvachSurgery Department, 2 Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic.
Carlos Alberto VaccaroInstituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)- CONICET- Universidad Hospital Italiano de Buenos Aires (UHIBA) y Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina.
Tamara Alejandra PiñeroInstituto de Medicina Traslacional e Ingeniería Biomédica (IMTIB)- CONICET- Universidad Hospital Italiano de Buenos Aires (UHIBA) y Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina.
Beata ŚwiątkowskaDepartment of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland.
Jolanta LissowskaThe Maria Sklodowska-Cure National Research Institute of Oncology, Warsaw, Poland.
Katarzyna Roszkowska-PurskaDepartment of Pathology, The Maria Sklodowska-Cure National Research Institute of Oncology, Warsaw, Poland.
Antonio Huertas-SalgadoOncological pathology group, Terry Fox National Tumor Bank (Banco Nacional de Tumores Terry Fox), National Cancer Institute, Bogotá, Colombia.
Tatsuhiro ShibataLaboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.
Satoshi ShibaDivision of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan.
Surasak SangkhathatTranslational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
Taned ChitapanaruxDepartment of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Patricia Ashton-ProllaDepartment of Genetics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Daniel C DaminDepartment of Surgery, Division of Colorectal Surgery, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil.
Francine Hehn de OliveiraDepartment of Pathology, Anatomic Pathology, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil.
Laura HumphreysCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Trevor D LawleyParasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
Sandra PerdomoGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Michael R StrattonCancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Paul BrennanGenomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Ludmil B AlexandrovDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0003-3596-4515

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Detecting Mutational Signatures of Environmental Mutagens in Heathy Individuals for Personalized Cancer PreventionR01ES032547 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALEXANDROV, LUDMIL B · 2021 to 2025
$3.4M
Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transitionU01CA290479 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ludmil B Alexandrov, Jorge Silvio Gutkind · 2023 to 2026
$3.1M
Comprehensive identification of germline-somatic interactionsR01CA269919 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ludmil B Alexandrov, Hannah Kathryn Carter · 2022 to 2026
$2.2M
NCI NIH HHS R01 CA269919NCI NIH HHS T32 CA067754NCI NIH HHS U01 CA167551NCI NIH HHS U01 CA290479NIEHS NIH HHS R01 ES032547Wellcome Trust
6 · The paper itself

Abstract

Colorectal cancer incidence rates vary geographically and have changed over time. Notably, in the past two decades, the incidence of early-onset colorectal cancer, affecting individuals under the age of 50 years, has doubled in many countries. The reasons for this increase are unknown. Here, we investigate whether mutational processes contribute to geographic and age-related differences by examining 981 colorectal cancer genomes from 11 countries. No major differences were found in microsatellite unstable cancers, but variations in mutation burden and signatures were observed in the 802 microsatellite-stable cases. Multiple signatures, most with unknown etiologies, exhibited varying prevalence in Argentina, Brazil, Colombia, Russia, and Thailand, indicating geographically diverse levels of mutagenic exposure. Signatures SBS88 and ID18, caused by the bacteria-produced mutagen colibactin, had higher mutation loads in countries with higher colorectal cancer incidence rates. SBS88 and ID18 were also enriched in early-onset colorectal cancers, being 3.3 times more common in individuals diagnosed before age 40 than in those over 70, and were imprinted early during colorectal cancer development. Colibactin exposure was further linked to

Identifiers

PMID40034755
PMCPMC11875255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.